Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LOGI
|
Bracken Darrell
President & CEO |
SELL
Open market or private sale
|
Direct | 41,666 Reduced 5.16% |
$3,264,114
$78.34 p/Share
|
Oct 01
2020 |
|
AGM
|
Zions Bancorporation, National Association /Ut/
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.32% |
$642,500
$64.25 p/Share
|
Oct 01
2020 |
|
EXAS
|
Kevin T Conroy
President and CEO |
SELL
Open market or private sale
|
Direct | 27,425 Reduced 2.89% |
$2,854,394
$104.08 p/Share
|
Oct 01
2020 |
|
DECK
|
Thomas Garcia
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 5.72% |
$229,000
$229.0 p/Share
|
Oct 01
2020 |
|
DECK
|
David E. Lafitte
COO |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.81% |
$111,325
$222.65 p/Share
|
Oct 01
2020 |
|
DKS
|
Lauren R Hobart
President & CEO |
SELL
Open market or private sale
|
Direct | 10,275 Reduced 5.81% |
$615,575
$59.91 p/Share
|
Oct 01
2020 |
|
DKS
|
John Edward Hayes Iii
SVP, General Counsel |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 13.13% |
$299,400
$59.88 p/Share
|
Oct 01
2020 |
|
ESTC
|
Janesh Moorjani
CFO & COO |
SELL
Open market or private sale
|
Direct | 14,733 Reduced 42.01% |
$1,647,297
$111.81 p/Share
|
Oct 01
2020 |
|
AXON
|
Michael Garnreiter
Director |
SELL
Open market or private sale
|
Direct | 500 Reduced 1.58% |
$45,920
$91.84 p/Share
|
Oct 01
2020 |
|
ALKS
|
Paul J Mitchell
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 74.07% |
$332,200
$16.61 p/Share
|
Oct 01
2020 |
|
W
|
Edmond Macri
Chief Product/Marketing |
SELL
Open market or private sale
|
Indirect | 1,500 Reduced 0.58% |
$449,775
$299.85 p/Share
|
Oct 01
2020 |
|
APLS
|
Federico Grossi
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 600 Reduced 2.07% |
$18,132
$30.22 p/Share
|
Oct 01
2020 |
|
ALTR
|
Brett R Chouinard
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 8.81% |
$127,800
$42.6 p/Share
|
Oct 01
2020 |
|
CVNA
|
Mark W. Jenkins
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 47.83% |
$2,402,500
$240.25 p/Share
|
Oct 01
2020 |
|
CVNA
|
Benjamin E. Huston
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 47.81% |
$2,400,000
$240.0 p/Share
|
Oct 01
2020 |
|
VIR
|
Jay Parrish
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 6,945 Reduced 3.03% |
$241,339
$34.75 p/Share
|
Oct 01
2020 |
|
NEWR
|
Lewis Cirne |
SELL
Open market or private sale
|
Indirect | 34,500 Reduced 0.29% |
$1,992,720
$57.76 p/Share
|
Oct 01
2020 |
|
APPN
|
Albert G.W. Biddle Iii
Director |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 1.48% |
$530,800
$66.35 p/Share
|
Oct 01
2020 |
|
VRNS
|
Fred Van Den Bosch
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.13% |
$116,150
$116.15 p/Share
|
Oct 01
2020 |
|
CHGG
|
John E. York
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 37.32% |
$733,800
$73.38 p/Share
|
Oct 01
2020 |
|
PFSI
|
Joseph F Mazzella
Director |
SELL
Open market or private sale
|
Indirect | 18,000 Reduced 3.62% |
$1,051,920
$58.44 p/Share
|
Oct 01
2020 |
|
PFSI
|
Jeffrey Grogin
Chief Enterprise Ops Officer |
SELL
Open market or private sale
|
Direct | 9,225 Reduced 24.29% |
$537,541
$58.27 p/Share
|
Oct 01
2020 |
|
FATE
|
Cindy Tahl |
SELL
Open market or private sale
|
Direct | 35,000 Reduced 26.02% |
$1,438,500
$41.1 p/Share
|
Oct 01
2020 |
|
ANGI
|
Jamie Cohen
CFO |
SELL
Open market or private sale
|
Direct | 4,273 Reduced 100.0% |
$52,344
$12.25 p/Share
|
Oct 01
2020 |
|
MED
|
Michael C Macdonald
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.84% |
$827,050
$165.41 p/Share
|
Oct 01
2020 |
|
TPH
|
Thomas J. Mitchell
President and COO |
SELL
Open market or private sale
|
Indirect | 159,138 Reduced 20.69% |
$2,944,053
$18.5 p/Share
|
Oct 01
2020 |
|
RAMP
|
James F. Arra
PRESIDENT AND CCO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 7.62% |
$777,300
$51.82 p/Share
|
Oct 01
2020 |
|
AAWW
|
William J Flynn
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 6.95% |
$305,750
$61.15 p/Share
|
Oct 01
2020 |
|
AMPH
|
Floyd F. Petersen |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.66% |
$9,445
$18.89 p/Share
|
Oct 01
2020 |
|
ALLO
|
Veer Bhavnagri
General Counsel |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 6.6% |
$924,750
$36.99 p/Share
|
Oct 01
2020 |
|
ALLO
|
Rafael Amado
EVP of R&D |
SELL
Open market or private sale
|
Direct | 9,752 Reduced 7.07% |
$354,680
$36.37 p/Share
|
Oct 01
2020 |
|
RVMD
|
Margaret A Horn
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 57,505 Reduced 46.64% |
$2,013,250
$35.01 p/Share
|
Oct 01
2020 |
|
SILK
|
Andrew S. Davis
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 6,635 Reduced 25.1% |
$435,256
$65.6 p/Share
|
Oct 01
2020 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct | 6,771 Reduced 100.0% |
$330,831
$48.86 p/Share
|
Oct 01
2020 |
|
ADPT
|
Eric Dobmeier
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 100.0% |
$488,400
$48.84 p/Share
|
Oct 01
2020 |
|
CDNA
|
Peter Maag |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 4.53% |
$816,400
$40.82 p/Share
|
Oct 01
2020 |
|
DRQ
|
James C. Webster
VP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 17.15% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
Raj Kumar
VP - CFO |
SELL
Open market or private sale
|
Direct | 1,995 Reduced 10.12% |
$47,940
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
Blake T. De Berry
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 4.63% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
DRQ
|
Jeffrey J. Bird
President & CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 13.54% |
$240,300
$24.03 p/Share
|
Oct 01
2020 |
|
HCAT
|
D Fraser Bullock |
SELL
Open market or private sale
|
Direct | 423 Reduced 0.61% |
$15,651
$37.0 p/Share
|
Oct 01
2020 |
|
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 11.68% |
$393,450
$36.6 p/Share
|
Oct 01
2020 |
|
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 2,242 Reduced 8.12% |
$82,237
$36.68 p/Share
|
Oct 01
2020 |
|
CCF
|
Adam Chase
President/CEO |
SELL
Open market or private sale
|
Indirect | 1,250 Reduced 0.63% |
$119,000
$95.2 p/Share
|
Oct 01
2020 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.62% |
$155,520
$38.88 p/Share
|
Oct 01
2020 |
|
QTRX
|
E Kevin Hrusovsky
Executive Chairman |
SELL
Open market or private sale
|
Direct | 3,286 Reduced 0.32% |
$112,118
$34.12 p/Share
|
Oct 01
2020 |
|
QTRX
|
Mark T. Roskey
SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct | 92 Reduced 0.43% |
$3,139
$34.12 p/Share
|
Oct 01
2020 |
|
QTRX
|
Amol Chaubal
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 116 Reduced 0.46% |
$3,958
$34.12 p/Share
|
Oct 01
2020 |
|
QTRX
|
John J Fry
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 143 Reduced 0.46% |
$4,879
$34.12 p/Share
|
Oct 01
2020 |
|
QTRX
|
Dawn Mattoon
Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct | 159 Reduced 0.5% |
$5,425
$34.12 p/Share
|
Oct 01
2020 |